Summary of Key Information:

Reporting Period (Quarter/Year): Quarter and Year ended 31st March, 2026

Nature of Filing / Announcement: Outcome of Board Meeting and Audited Financial Results pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015

Audit Opinion:

Unmodified opinion issued by M/s V.K. Khosla & Co., Chartered Accountants (FRN: 002283N)

Key Financial Highlights [Rs. in lakhs]:

Standalone Results:

Quarter Ended 31 March 2026:

  • Revenue from Operations: 3,269.57
  • Total Income: 3,342.23
  • Net Profit/(Loss): (356.56)
  • EPS: (0.42)

Year Ended 31 March 2026:

  • Revenue from Operations: 10,169.47 (vs. 9,199.73 in FY25)
  • Total Income: 10,514.34 (vs. 9,487.44 in FY25)
  • Net Profit/(Loss): (191.73) (improved from (1,973.84) in FY25)
  • EPS: (0.22) (improved from (2.37) in FY25)
  • Other Equity: 8,767.17
  • Cash and Cash Equivalents: 373.67
  • Debt: Short-term borrowings: 929.45; Long-term borrowings: 551.78; Total debt: 1,481.23

Consolidated Results:

Year Ended 31 March 2026:

  • Revenue from Operations: 10,169.47
  • Total Income: 10,514.34
  • Net Profit/(Loss): (192.24) (improved from (1,974.43) in FY25)
  • EPS: (0.22) (improved from (2.37) in FY25)
  • Other Equity: 8,726.16
  • Cash and Cash Equilibvalents: 375.42

Segment-wise Performance:

The Company has only one reportable operating segment as per Ind AS 108 - manufacturing of oral care products.

Corporate Actions:

  • No dividend declared or paid during the year
  • The Company allotted on preferential basis on 3rd August 2024:
  • 72,07,204 equity shares at Rs. 27.75 per share aggregating to Rs. 2000 lakhs to "Non-Promoter" Category
  • 36,03,602 fully convertible warrants at Rs. 27.75 per warrant aggregating to Rs. 1000 lakhs to "Promoter & Promoter Group" and "Non-Promoter" Categories
  • On 1st February 2026, 18,01,801 warrants were converted into equity shares and 18,01,801 warrants lapsed due to non-conversion
  • Paid-up equity share capital stands at ₹87,40,57,670 comprising 8,74,05,767 equity shares of face value ₹10/- each

Fund Utilization from Preferential Issue:

  • Project in Jammu and Kashmir: Rs. 71.29 lakhs
  • General Corporate Purpose: Rs. 749.50 lakhs
  • Investment in Preferential Warrants of JHS Svendgaard Retail Ventures Limited: Rs. 112.50 lakhs
  • Capital Expenditure: Rs. 465.11 lakhs
  • Balance parked in fixed deposits: Rs. 1226.60 lakhs

Other Significant Information:

  • The Company holds significant capital advances of Rs. 4,190.82 lakhs (Rs. 2,862.52 lakhs for HP projects + Rs. 1,328.30 lakhs for J&K project) which management considers recoverable
  • The Company needs to strengthen Cost Records as per section 148 of Companies Act
  • Material weaknesses identified in internal financial controls including:
  • Controls over monitoring and reconciliation of trade receivables and trade payables
  • Process for material samples and disposal of rejected inventory
  • Tracking of direct tax balances
  • Reconciliation of TDS and TCS balances
  • Automated alerts for TDS deduction under Section 194Q
  • Monitoring mechanism for non-moving and dead stock inventory

Entities Included in Consolidation:

  • JHS Svendgaard Mechanical and Warehouse Private Limited (Wholly Owned Subsidiary)